
The following company is one of the companies presenting at the 22nd Annual Investors Choice Venture Capital Conference. It is part of a group of presenting companies that are classified as being Early Stage – Founder or Angel backed and/or having annual sales less than $1 million
Phoenix Pharmalabs, Inc. – Drug Discovery Logan, UT
Phoenix PharmaLabs, Inc. uses a proprietary technology (“ChemMod”) to modify the structures of existing, best-selling drugs into new chemical entities for further drug development. The ChemMod technology is broadly enabling and can revolutionize drug discovery by creating “new and improved” versions of 80% of current blockbuster drugs. PPL has applied this technology to create a first (“Opioids”) technology bundle comprised of novel analogs of conventional opioids (e. g., morphine) – with greatly improved properties relative to those drugs.





Comment Preview